Lucid Diagnostics Inc

LUCD

Company Profile

  • Business description

    Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

  • Contact

    360 Madison Avenue
    25th Floor
    New YorkNY10017
    USA

    T: +1 917 813-1828

    https://www.luciddx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    82

Stocks News & Analysis

stocks

Overvalued ASX share has overly ambitious profit target

We think the new profit target is aggressive and unlikely to be met.
stocks

7 undervalued US stocks that crushed earnings

Arista and GE Vernova remain among the cheapest Morningstar-covered stocks after strong earnings beats.
stocks

Undervalued ASX share hitting on all cylinders

Strong performance across all segments in latest earnings release.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,008.00157.40-1.72%
CAC 408,352.0016.91-0.20%
DAX 4026,598.64151.31-0.57%
Dow JONES (US)51,608.17739.38-1.41%
FTSE 10010,881.5521.01-0.19%
HKSE23,578.65175.19-0.74%
NASDAQ24,509.76626.52-2.49%
Nikkei 22558,956.67705.35-1.18%
NZX 50 Index14,350.6846.910.33%
S&P 5007,416.59145.08-1.92%
S&P/ASX 2008,892.00152.70-1.69%
SSE Composite Index3,591.8910.68-0.30%

Market Movers